These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36866568)

  • 1. High-Density IgG4+ Plasma Cells Infiltration Is Associated With Fibroplasia in Fibrostenotic Crohn's Disease.
    Escobar D; Bushara O; Sun L; Liao J; Yang GY
    Int J Surg Pathol; 2023 Sep; 31(6):1085-1092. PubMed ID: 36866568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Possible Pathogenic Role of IgG4-Producing Plasmablasts in Stricturing Crohn's Disease.
    Bushara O; Escobar DJ; Weinberg SE; Sun L; Liao J; Yang GY
    Pathobiology; 2022; 89(4):187-197. PubMed ID: 35026755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue IgG4-positive plasma cells in inflammatory bowel disease: a study of 88 treatment-naive biopsies of inflammatory bowel disease.
    Virk R; Shinagare S; Lauwers GY; Yajnik V; Stone JH; Deshpande V
    Mod Pathol; 2014 Mar; 27(3):454-9. PubMed ID: 23929268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smooth Muscle Hyperplasia/Hypertrophy is the Most Prominent Histological Change in Crohn's Fibrostenosing Bowel Strictures: A Semiquantitative Analysis by Using a Novel Histological Grading Scheme.
    Chen W; Lu C; Hirota C; Iacucci M; Ghosh S; Gui X
    J Crohns Colitis; 2017 Jan; 11(1):92-104. PubMed ID: 27364949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computed tomography enterography findings correlate with tissue inflammation, not fibrosis in resected small bowel Crohn's disease.
    Adler J; Punglia DR; Dillman JR; Polydorides AD; Dave M; Al-Hawary MM; Platt JF; McKenna BJ; Zimmermann EM
    Inflamm Bowel Dis; 2012 May; 18(5):849-56. PubMed ID: 21710535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel collagen area fraction index to quantitatively assess bowel fibrosis in patients with Crohn's disease.
    Li XH; Fang ZN; Guan TM; Lin JJ; Sun CH; Huang SY; Mao R; Lu BL; Cao QH; Feng ST; Li ZP
    BMC Gastroenterol; 2019 Nov; 19(1):180. PubMed ID: 31711420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative apparent diffusion coefficient (ADC) values as an imaging biomarker for fibrosis in pediatric Crohn's disease: preliminary experience.
    Kovanlikaya A; Beneck D; Rose M; Renjen P; Dunning A; Solomon A; Sockolow R; Brill PW
    Abdom Imaging; 2015 Jun; 40(5):1068-74. PubMed ID: 25248794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International consensus to standardise histopathological scoring for small bowel strictures in Crohn's disease.
    Gordon IO; Bettenworth D; Bokemeyer A; Srivastava A; Rosty C; de Hertogh G; Robert ME; Valasek MA; Mao R; Li J; Harpaz N; Borralho P; Pai RK; Odze R; Feakins R; Parker CE; Guizzetti L; Nguyen T; Shackelton LM; Sandborn WJ; Jairath V; Baker M; Bruining D; Fletcher JG; Feagan BG; Pai RK; Rieder F;
    Gut; 2022 Mar; 71(3):479-486. PubMed ID: 33952604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal stricture in Crohn's disease: A 2020 update.
    Lin XX; Qiu Y; Zhuang XJ; Liu F; Wu XM; Chen MH; Mao R
    J Dig Dis; 2021 Jul; 22(7):390-398. PubMed ID: 34014617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensive drug therapy versus standard drug therapy for symptomatic intestinal Crohn's disease strictures (STRIDENT): an open-label, single-centre, randomised controlled trial.
    Schulberg JD; Wright EK; Holt BA; Hamilton AL; Sutherland TR; Ross AL; Vogrin S; Miller AM; Connell WC; Lust M; Ding NS; Moore GT; Bell SJ; Shelton E; Christensen B; De Cruz P; Rong YJ; Kamm MA
    Lancet Gastroenterol Hepatol; 2022 Apr; 7(4):318-331. PubMed ID: 34890567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history, diagnosis and treatment approach to fibrostenosing Crohn's disease.
    El Ouali S; Click B; Holubar SD; Rieder F
    United European Gastroenterol J; 2020 Apr; 8(3):263-270. PubMed ID: 32213020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum biomarkers of fibrostenotic Crohn's disease: Where are we now?
    He JS; Tan JY; Li XZ; Feng R; Xiong SS; Lin SN; Qiu Y; Mao R
    J Dig Dis; 2020 Jun; 21(6):336-341. PubMed ID: 32496631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small bowel stricture is associated with abnormal motility on the cine MRI sequence in patients with Crohn's disease.
    Lambrou T; Chaudhry NA; Grajo JR; Moser P; Riverso M; Mramba LK; Zimmermann EM
    Eur J Radiol; 2019 Sep; 118():264-270. PubMed ID: 31439253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bowel stiffness associated with histopathologic scoring of stenosis in patients with Crohn's disease.
    Zhao J; Liao D; Wilkens R; Krogh K; Glerup H; Gregersen H
    Acta Biomater; 2021 Aug; 130():332-342. PubMed ID: 34119715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of small bowel TGFβ1 and TGFβ3 characterizes intestinal strictures in patients with fibrostenotic Crohn's disease.
    Levitte S; Khan I; Iyahen V; Ziai J; Gubatan J; Sheng R; Glickstein SB; Sun T; Park KT; McBride J; Keir M
    Histochem Cell Biol; 2024 Sep; 162(3):225-230. PubMed ID: 38705911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transmural Histological Scoring Systems in Crohn's Disease: A Systematic Review With Assessment of Methodological Quality and Operating Properties.
    Tavares de Sousa H; Estevinho MM; Peyrin-Biroulet L; Danese S; Dias CC; Carneiro F; Magro F
    J Crohns Colitis; 2020 Jul; 14(6):743-756. PubMed ID: 31985012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The analysis of clinico-pathologic characteristics in patients who underwent surgery due to stricturing and non-perineal fistulizing forms of Crohn's disease: a retrospective cohort study.
    Cayci M; Bostanci EB; Turhan N; Karaman K; Dalgic T; Ozer I; Ercan M; Ulas M; Akoglu M
    Int J Surg; 2015 Mar; 15():49-54. PubMed ID: 25647540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal IgG4 cell infiltration in ulcerative colitis is linked to disease activity and primary sclerosing cholangitis.
    Raina A; Yadav D; Regueiro M; Krasinskas AM; Saul MI; Sapienza DA; Binion DG; Hartman DJ
    Inflamm Bowel Dis; 2013 May; 19(6):1232-7. PubMed ID: 23619716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local Pentraxin-2 Deficit Is a Feature of Intestinal Fibrosis in Crohn's Disease.
    Levitte S; Peale FV; Jhun I; McBride J; Neighbors M
    Dig Dis Sci; 2023 Jul; 68(7):2975-2980. PubMed ID: 36884186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic change and accumulation of smooth muscle cells in strictures in Crohn's disease: relevance to local angiotensin II system.
    Suekane T; Ikura Y; Watanabe K; Arimoto J; Iwasa Y; Sugama Y; Kayo S; Sugioka K; Naruko T; Maeda K; Hirakawa K; Arakawa T; Ueda M
    J Gastroenterol; 2010 Aug; 45(8):821-30. PubMed ID: 20361214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.